Molecular Diagnostics Market, Global Forecast by Application, Technology, End User, Regions, Companies
Global Molecular Diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing a significant growth during the forecast period. Some of the key factors that can be attributed to the growth of the molecular diagnostics market include rising prevalence of diseases, including cancers, growing awareness and acceptance of companion & personalized diagnostics and advancement in the molecular diagnostics techniques. Furthermore; rising incidence of neurological, cardiovascular and genetic disorders also helps molecular diagnostics market thrive in the coming years.
It is believed that development in molecular diagnostics has facilitated early detection of various diseases which possibly could result in major socioeconomic burden. According to WHO; the average prevalence of health care-associated infection varies between 3.5% and 12% in developed countries. While, the European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. Molecular diagnostics plays a significant role in the diagnosis of infectious diseases as they provide effective results in no time.
Renub Research report titled “Molecular Diagnostics Market, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others)” provides a complete analysis of Molecular Diagnostics Market.
By Application – Infectious Disease Testing holds the Maximum Market Share
The report studies the market of the following Diagnostics segments: Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others.
By Technology – PCR Segment is leading the market and will continue so during the Forecast period
On the basis of technology, the molecular diagnostics market has been broadly segmented into PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others.
By End User – Hospitals & Academic Laboratory holds the Largest Market
The report studies the market of the following End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others.
By Regions – United States and Europe dominates the Molecular Diagnostics Market
United States and Europe together controls the Molecular Diagnostics Market. In addition; the report also provides the complete geographical analysis India, China, Japan, Brazil, South Korea, Mexico, Russia and Rest of World Molecular Diagnostics Market.
Roche, Abbott, Myriad Genetics, Qiagen and BioMérieux are some of the top companies operating in the Molecular Diagnostics; which has been studied thoroughly in the report.
This market research report provides a complete analysis of the Molecular Diagnostics Market, Growth Drivers, Challenges, and their projections for the upcoming years.
• Infectious Diseases
• Blood Screening
• Genetic Testing
• HLA (Tissue Typing)
• Cardiovascular Diseases
• Neurological Diseases
• Transcription-Mediated Amplification (TMA)
• Hybridiazation (In-situ Hybridiazation & FISH)
• DNA Sequencing & NGS
By End User
• Hospitals & Academic Laboratories
• Clinics & Commercial Laboratories
• United States
• Europe (Expect Russia)
• South Korea
• Rest of World
• Myriad Genetics